NDC 52584-269

Diprivan

Diprivan

Diprivan is a Intravenous Injection, Emulsion in the Human Prescription Drug category. It is labeled and distributed by General Injectables & Vaccines, Inc. The primary component is Propofol.

Product ID52584-269_bc7ce430-9a37-4654-b256-3a7ef0643e9b
NDC52584-269
Product TypeHuman Prescription Drug
Proprietary NameDiprivan
Generic NameDiprivan
Dosage FormInjection, Emulsion
Route of AdministrationINTRAVENOUS
Marketing Start Date2010-03-01
Marketing CategoryNDA / NDA
Application NumberNDA019627
Labeler NameGeneral Injectables & Vaccines, Inc
Substance NamePROPOFOL
Active Ingredient Strength10 mg/mL
Pharm ClassesGeneral Anesthesia [PE],General Anesthetic [EPC]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC SPL Data Element Entries

NDC 52584-269-50 [52584026950]

Diprivan INJECTION, EMULSION
Marketing CategoryNDA
Application NumberNDA019627
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-03-01
Marketing End Date2017-01-18
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
PROPOFOL10 mg/mL

OpenFDA Data

SPL SET ID:7603f1ba-cfbd-4ec5-881a-13f4832c9893
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1808222
  • Pharmacological Class

    • General Anesthesia [PE]
    • General Anesthetic [EPC]

    NDC Crossover Matching brand name "Diprivan" or generic name "Diprivan"

    NDCBrand NameGeneric Name
    52584-269DiprivanDiprivan
    63323-269DiprivanPROPOFOL
    65219-800DiprivanPROPOFOL

    Trademark Results [Diprivan]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DIPRIVAN
    DIPRIVAN
    73441920 1304645 Live/Registered
    Imperial Chemical Industries PLC
    1983-09-01

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.